Pesquisa | BVS Doenças Infecciosas e Parasitárias

1.

Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma.

Westin, Jason R; Oluwole, Olalekan O; Kersten, Marie José; Miklos, David B; Perales, Miguel-Angel; Ghobadi, Armin; Rapoport, Aaron P; Sureda, Anna; Jacobson, Caron A; Farooq, Umar; van Meerten, Tom; Ulrickson, Matthew; Elsawy, Mahmoud; Leslie, Lori A; Chaganti, Sridhar; Dickinson, Michael; Dorritie, Kathleen; Reagan, Patrick M; McGuirk, Joseph; Song, Kevin W; Riedell, Peter A; Minnema, Monique C; Yang, Yin; Vardhanabhuti, Saran; Filosto, Simone; Cheng, Paul; Shahani, Shilpa A; Schupp, Marco; To, Christina; Locke, Frederick L.

N Engl J Med ; 389(2): 148-157, 2023 Jul 13.

Artigo em Inglês | MEDLINE | ID: mdl-37272527

2.

Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma.

Locke, Frederick L; Miklos, David B; Jacobson, Caron A; Perales, Miguel-Angel; Kersten, Marie-José; Oluwole, Olalekan O; Ghobadi, Armin; Rapoport, Aaron P; McGuirk, Joseph; Pagel, John M; Muñoz, Javier; Farooq, Umar; van Meerten, Tom; Reagan, Patrick M; Sureda, Anna; Flinn, Ian W; Vandenberghe, Peter; Song, Kevin W; Dickinson, Michael; Minnema, Monique C; Riedell, Peter A; Leslie, Lori A; Chaganti, Sridhar; Yang, Yin; Filosto, Simone; Shah, Jina; Schupp, Marco; To, Christina; Cheng, Paul; Gordon, Leo I; Westin, Jason R.

N Engl J Med ; 386(7): 640-654, 2022 02 17.

Artigo em Inglês | MEDLINE | ID: mdl-34891224

3.

Treatment of secondary CNS lymphoma using CD19-targeted chimeric antigen receptor (CAR) T cells.

Kline, Kathryn; Luetkens, Tim; Koka, Rima; Kallen, Michael E; Chen, Wengen; Ahmad, Haroon; Omili, Destiny; Iraguha, Thierry; Gebru, Etse; Fan, Xiaoxuan; Miller, Alexis; Dishanthan, Nishanthini; Baker, Jillian M; Dietze, Kenneth A; Hankey, Kim G; Yared, Jean A; Hardy, Nancy M; Rapoport, Aaron P; Dahiya, Saurabh; Atanackovic, Djordje.

Cancer Immunol Immunother ; 73(3): 45, 2024 Feb 13.

Artigo em Inglês | MEDLINE | ID: mdl-38349430

4.

Defibrotide improves COVID-19-related acute respiratory distress syndrome in myeloma patients after chimeric antigen receptor T-cell treatment without compromising virus-specific and anti-myeloma T-cell responses.

Kocoglu, Mehmet H; Richardson, Paul G; Mo, Clifton C; Rapoport, Aaron P; Atanackovic, Djordje.

Haematologica ; 2024 Feb 22.

Artigo em Inglês | MEDLINE | ID: mdl-38385273

5.

A novel multicolor fluorescent spot assay for the functional assessment of chimeric antigen receptor (CAR) T-cell products.

Atanackovic, Djordje; Iraguha, Thierry; Omili, Destiny; Avila, Stephanie V; Fan, Xiaoxuan; Kocoglu, Mehmet; Gebru, Etse; Baker, Jillian M; Dishanthan, Nishanthini; Dietze, Kenneth A; Oluwafemi, Ayooluwakiitan; Hardy, Nancy M; Yared, Jean A; Hankey, Kim; Dahiya, Saurabh; Rapoport, Aaron P; Luetkens, Tim.

Cytotherapy ; 26(4): 318-324, 2024 Apr.

Artigo em Inglês | MEDLINE | ID: mdl-38340107

6.

Phase I/II clinical trial of temsirolimus and lenalidomide in patients with relapsed and refractory lymphomas.

Major, Ajay; Kline, Justin; Karrison, Theodore G; Fishkin, Paul A S; Kimball, Amy S; Petrich, Adam M; Nattam, Sreenivasa; Rao, Krishna; Sleckman, Bethany G; Cohen, Kenneth; Besien, Koen van; Rapoport, Aaron P; Smith, Sonali M.

Haematologica ; 107(7): 1608-1618, 2022 07 01.

Artigo em Inglês | MEDLINE | ID: mdl-34320785

7.

The impact of bridging therapy prior to CD19-directed chimeric antigen receptor T-cell therapy in patients with large B-cell lymphoma.

Lutfi, Forat; Holtzman, Noa G; Kansagra, Ankit J; Mustafa Ali, Moaath; Bukhari, Ali; Yan, Jingsheng; Samanta, Santanu; Gottlieb, David; Kim, Dong W; Matsumoto, Lisa R; Gahres, Natalie; Ruehle, Kathleen; Lee, Seung T; Law, Jennie Y; Kocoglu, Mehmet H; Atanackovic, Djordje; Yared, Jean A; Hardy, Nancy M; Molitoris, Jason; Mohindra, Pranshu; Rapoport, Aaron P; Dahiya, Saurabh.

Br J Haematol ; 195(3): 405-412, 2021 11.

Artigo em Inglês | MEDLINE | ID: mdl-34500492

8.

Toxoplasma-induced hemophagocytic lymphohistiocytosis after haploidentical allogeneic stem cell transplantation.

Sanchez-Petitto, Gabriela; Holtzman, Noa G; Bukhari, Ali; Brown, Matthew; Morales, Megan K; Koka, Madhurima; Yared, Jean A; Dahiya, Saurabh; Rapoport, Aaron P; Hardy, Nancy M.

Transpl Infect Dis ; 22(2): e13242, 2020 Apr.

Artigo em Inglês | MEDLINE | ID: mdl-31895492

9.

Phase 1 study of lenalidomide plus dose-adjusted EPOCH-R in patients with aggressive B-cell lymphomas with deregulated MYC and BCL2.

Godfrey, James K; Nabhan, Chadi; Karrison, Theodore; Kline, Justin P; Cohen, Kenneth S; Bishop, Michael R; Stadler, Walter M; Karmali, Reem; Venugopal, Parameswaran; Rapoport, Aaron P; Smith, Sonali M.

Cancer ; 125(11): 1830-1836, 2019 06 01.

Artigo em Inglês | MEDLINE | ID: mdl-30707764

10.

Pembrolizumab, pomalidomide, and low-dose dexamethasone for relapsed/refractory multiple myeloma.

Badros, Ashraf; Hyjek, Elizabeth; Ma, Ning; Lesokhin, Alexander; Dogan, Ahmet; Rapoport, Aaron P; Kocoglu, Mehmet; Lederer, Emily; Philip, Sunita; Milliron, Todd; Dell, Cameron; Goloubeva, Olga; Singh, Zeba.

Blood ; 130(10): 1189-1197, 2017 09 07.

Artigo em Inglês | MEDLINE | ID: mdl-28461396

11.

Vaccine-induced T-cell responses against SARS-CoV-2 and its Omicron variant in patients with B cell-depleted lymphoma after CART therapy.

Atanackovic, Djordje; Luetkens, Tim; Omili, Destiny; Iraguha, Thierry; Lutfi, Forat; Hardy, Nancy M; Fan, Xiaoxuan; Avila, Stephanie V; Saharia, Kapil K; Husson, Jennifer S; Niederhaus, Silke V; Margiotta, Philip; Lee, Seung T; Law, Jennie Y; Mannuel, Heather D; Vander Mause, Erica; Bauman, Sherri; Lesho, Patricia; Hankey, Kim; Baddley, John; Kocoglu, Mehmet; Yared, Jean A; Rapoport, Aaron P; Dahiya, Saurabh.

Blood ; 140(2): 152-156, 2022 07 14.

Artigo em Inglês | MEDLINE | ID: mdl-35537186

12.

Anti-CD19 chimeric antigen receptor T-cell therapy for B-cell acute lymphoid leukemia.

Rapoport, Aaron P.

Haematologica ; 109(4): 1019-1020, 2024 Apr 01.

Artigo em Inglês | MEDLINE | ID: mdl-38562075

13.

Immune-mediated facial nerve paralysis in a myeloma patient post B-cell maturation antigen-targeted chimeric antigen receptor T cells.

Kathari, Yamini K; Ahmad, Haroon; Kallen, Michael E; Koka, Rima; Omili, Destiny; Iraguha, Thierry; Clement, Jean; Pham, Lily; Khalid, Mazhar; Fan, Xiaoxuan; Gebru, Etse; Lesho, Patricia; Park, Esther; Dishanthan, Nishanthini; Baker, Jillian M; Dietze, Kenneth A; Hankey, Kim G; Badros, Ashraf; Yared, Jean A; Dahiya, Saurabh; Hardy, Nancy M; Kocoglu, Hakan; Luetkens, Tim; Rapoport, Aaron P; Atanackovic, Djordje.

Haematologica ; 109(2): 682-688, 2024 Feb 01.

Artigo em Inglês | MEDLINE | ID: mdl-37675514

14.

Outcomes of patients with large B-cell lymphoma progressing after axicabtagene ciloleucel therapy.

Spiegel, Jay Y; Dahiya, Saurabh; Jain, Michael D; Tamaresis, John; Nastoupil, Loretta J; Jacobs, Miriam T; Ghobadi, Armin; Lin, Yi; Lunning, Matthew; Lekakis, Lazaros; Reagan, Patrick; Oluwole, Olalekan; McGuirk, Joseph; Deol, Abhinav; Goy, Andre; Vu, Khoan; Andreadis, Charalambos; Munoz, Javier; Bennani, N Nora; Vose, Julie M; Dorritie, Kathleen A; Neelapu, Sattva S; Locke, Frederick L; Rapoport, Aaron P; Hill, Brian T; Miklos, David B.

Blood ; 137(13): 1832-1835, 2021 04 01.

Artigo em Inglês | MEDLINE | ID: mdl-33156925

15.

Myeloma escape from immunity: an "inside" job.

Rapoport, Aaron P.

Blood ; 126(12): 1401-3, 2015 Sep 17.

Artigo em Inglês | MEDLINE | ID: mdl-26384282

16.

Check(point) or checkmate for acute myeloid leukemia?

Niyongere, Sandrine; Rapoport, Aaron P.

Haematologica ; 106(5): 1230-1231, 2021 05 01.

Artigo em Inglês | MEDLINE | ID: mdl-33538155

17.

Disparities in black and white patients with multiple myeloma referred for autologous hematopoietic transplantation: a single center study.

Bhatnagar, Vishal; Wu, Yin; Goloubeva, Olga G; Ruehle, Kathleen T; Milliron, Todd E; Harris, Carolynn G; Rapoport, Aaron P; Yanovich, Saul; Sausville, Edward A; Baer, Maria R; Badros, Ashraf Z.

Cancer ; 121(7): 1064-70, 2015 Apr 01.

Artigo em Inglês | MEDLINE | ID: mdl-25469920

18.

Donating used CARs.

Rapoport, Aaron P.

Blood ; 122(25): 4007-9, 2013 Dec 12.

Artigo em Inglês | MEDLINE | ID: mdl-24335030

19.

Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma.

Linette, Gerald P; Stadtmauer, Edward A; Maus, Marcela V; Rapoport, Aaron P; Levine, Bruce L; Emery, Lyndsey; Litzky, Leslie; Bagg, Adam; Carreno, Beatriz M; Cimino, Patrick J; Binder-Scholl, Gwendolyn K; Smethurst, Dominic P; Gerry, Andrew B; Pumphrey, Nick J; Bennett, Alan D; Brewer, Joanna E; Dukes, Joseph; Harper, Jane; Tayton-Martin, Helen K; Jakobsen, Bent K; Hassan, Namir J; Kalos, Michael; June, Carl H.

Blood ; 122(6): 863-71, 2013 Aug 08.

Artigo em Inglês | MEDLINE | ID: mdl-23770775

20.

Severe dysautonomia as a manifestation of neurotoxicity after CAR-T cell therapy for diffuse large B-cell lymphoma.

El Chaer, Firas; Siegel, Ariel; Holtzman, Noa G; Bukhari, Ali; Lutfi, Forat; Shah, Nirav G; Yared, Jean A; Rapoport, Aaron P; McCurdy, Michael T; Dahiya, Saurabh.

Am J Hematol ; 95(6): E146-E148, 2020 06.

Artigo em Inglês | MEDLINE | ID: mdl-32233094

BVS Doenças Infecciosas e Parasitárias

Informação e Conhecimento para a Saúde

Configurar filtros

Sua seleção (0)

Formato de exportação:

Exportar:

Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma.

Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma.

Treatment of secondary CNS lymphoma using CD19-targeted chimeric antigen receptor (CAR) T cells.

Defibrotide improves COVID-19-related acute respiratory distress syndrome in myeloma patients after chimeric antigen receptor T-cell treatment without compromising virus-specific and anti-myeloma T-cell responses.

A novel multicolor fluorescent spot assay for the functional assessment of chimeric antigen receptor (CAR) T-cell products.

Phase I/II clinical trial of temsirolimus and lenalidomide in patients with relapsed and refractory lymphomas.

The impact of bridging therapy prior to CD19-directed chimeric antigen receptor T-cell therapy in patients with large B-cell lymphoma.

Toxoplasma-induced hemophagocytic lymphohistiocytosis after haploidentical allogeneic stem cell transplantation.

Phase 1 study of lenalidomide plus dose-adjusted EPOCH-R in patients with aggressive B-cell lymphomas with deregulated MYC and BCL2.

Pembrolizumab, pomalidomide, and low-dose dexamethasone for relapsed/refractory multiple myeloma.

Vaccine-induced T-cell responses against SARS-CoV-2 and its Omicron variant in patients with B cell-depleted lymphoma after CART therapy.

Anti-CD19 chimeric antigen receptor T-cell therapy for B-cell acute lymphoid leukemia.

Immune-mediated facial nerve paralysis in a myeloma patient post B-cell maturation antigen-targeted chimeric antigen receptor T cells.

Outcomes of patients with large B-cell lymphoma progressing after axicabtagene ciloleucel therapy.

Myeloma escape from immunity: an "inside" job.

Check(point) or checkmate for acute myeloid leukemia?

Disparities in black and white patients with multiple myeloma referred for autologous hematopoietic transplantation: a single center study.

Donating used CARs.

Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma.

Severe dysautonomia as a manifestation of neurotoxicity after CAR-T cell therapy for diffuse large B-cell lymphoma.